# Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension

Study · id `cardio:ct-nct04559074` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04559074](<https://clinicaltrials.gov/study/NCT04559074>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04559074

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 343 participants.

## Technical summary

Registry record NCT04559074. Non-randomized; no masking; primary purpose treatment. Start 2020-10-23 (actual); primary completion 2021-11-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 343 participants (enrolled count; ClinicalTrials.gov record NCT04559074, source copy `cardio:ctgov-nct04559074-2024-02-13`, retrieved 2026-10-26)
- Started: 2020-10-23 (actual) (ClinicalTrials.gov record NCT04559074, source copy `cardio:ctgov-nct04559074-2024-02-13`, retrieved 2026-10-26)
- Primary completion: 2021-11-10 (actual) (ClinicalTrials.gov record NCT04559074, source copy `cardio:ctgov-nct04559074-2024-02-13`, retrieved 2026-10-26)
- Completion: 2021-11-19 (actual) (ClinicalTrials.gov record NCT04559074, source copy `cardio:ctgov-nct04559074-2024-02-13`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT04559074, source copy `cardio:ctgov-nct04559074-2024-02-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04559074-2024-02-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension
- Acronym: PERSONALCovdBP
- Condition: Hypertension
- Intervention (Drug): Amlodipine
- Lead sponsor: Queen Mary University of London
- Lead sponsor class: OTHER
- Collaborator: Closed Loop Medicine Ltd
- Collaborator class: UNKNOWN
- Collaborator: Innovate UK
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Amlodipine (`cardio:amlodipine`)
- Registry intervention is a member of this class by a sourced record link: Calcium channel blockers (`cardio:calcium-channel-blockers`)
- Registry lists this organization as the lead sponsor: Queen Mary University of London (`cardio:org-queen-mary-university-of-london`)

## Provenance

Content hash: c78457089d8ab72c71eab3766a51617e311fdde7b47210f7b5a6ccf1d0d58019
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
